EUVIMEDEUVIMED entdecken
Crossref

Patterns of Response to Durvalumab Plus Tremelimumab and Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

Akifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, Taikan Hamamoto, Ryotaro Tanaka, Kazuki Kurosaka, Hideo Suzuki, Kenta Motomura

Anticancer Research · 2026

DOI: 10.21873/anticanres.18366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Akifumi Kuwano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan; akuwanoh1@aih-net.com. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularAntibodies, Monoclonal, HumanizedAntibodies, MonoclonalBevacizumabAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleAgedRetrospective StudiesMiddle AgedTreatment OutcomeAged, 80 and overAdult

Stichwörter der Autor:innen

Hepatocellular carcinomaatezolizumab plus bevacizumabdepth of responsedurable responsedurvalumab plus tremelimumabtumor shrinkage

Substanzen

Antibodies, Monoclonal, HumanizedAntibodies, MonoclonalBevacizumabatezolizumabtremelimumabdurvalumab

Autor:innen und Institutionen

  • Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan; akuwanoh1@aih-net.com.
  • Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan.
  • Department of Gastroenterology, Ichinomiyanishi Hospital, Ichinomiya, Japan.

Zitieren

APA

Kuwano, A., Yada, M., Tanaka, K., Hamamoto, T., Tanaka, R., Kurosaka, K., Suzuki, H., & Motomura, K. (2026). Patterns of Response to Durvalumab Plus Tremelimumab and Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.18366

Vancouver

Kuwano A, Yada M, Tanaka K, Hamamoto T, Tanaka R, Kurosaka K, et al. Patterns of Response to Durvalumab Plus Tremelimumab and Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma. Anticancer Research. 2026. doi:10.21873/anticanres.18366

BibTeX
@article{Kuwano2026,
  author = {Kuwano, Akifumi and Yada, Masayoshi and Tanaka, Kosuke and Hamamoto, Taikan and Tanaka, Ryotaro and Kurosaka, Kazuki and Suzuki, Hideo and Motomura, Kenta},
  title = {Patterns of Response to Durvalumab Plus Tremelimumab and Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18366}
}
Kostenlos starten →